Menu

地诺单抗国内售价多少钱?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is a new RANKL inhibitor for the treatment of adults and skeletally mature adolescent patients with unresectable giant cell tumors of bone or whose surgical resection may result in severe functional impairment. As early as May 28, 2010, the European Commission approved denosumab for the treatment of bone loss associated with hormone suppression in postmenopausal women with osteoporosis and prostate cancer. It can also be used in patients who are currently ineffective or intolerant to other treatments to reduce the risk of fractures. In June of the same year, denosumab was approved by the FDA for marketing.

In 2018, denosumab was included in the list of overseas new drugs in urgent clinical need (first batch) and entered the rapid review channel of the National Medical Products Administration. This approval makes denosumab the first and currently the only drug for the treatment of giant cell tumor of bone, bringing patients an innovative treatment option to control disease progression and improve quality of life. On May 27, 2019, Amgen China announced that denosumab has been approved by the National Medical Products Administration for the treatment of giant cell tumors of bone that are unresectable or whose surgical resection may cause severe functional impairment, including adults and adolescent patients with skeletal maturity (defined as at least 1 mature long bone and a body weight ≥45 kg). 

The launch of denosumab in my country has attracted widespread attention, and the price of denosumab is one of the things that patients are most concerned about. So what is the price of denosumab in China?

Because it is conditionally approved for marketing in China and has not been fully popularized, the domestic price of denosumab is not very clear. According to past experience, the price of new drugs on the market in my country is relatively high, and many families are often unable to afford it. In addition to my country, denosumab is also on the market in Turkey. It is also an original drug with a relatively low price. The specification is 125mg/1ml tube/box, and the price is about 3,000$ equivalent to RMB.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。